Treatment with Repository Corticotropin Injection in Patients with Rheumatoid Arthritis, Systemic Lupus Erythematosus, and Dermatomyositis/Polymyositis

PURPOSE: Repository corticotropin injection (RCI) is indicated for a number of autoimmune-mediated diseases including rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and dermatomyositis (DM)/polymyositis (PM). To better understand the practice patterns and outcomes of RCI in patients...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Open Access Rheumatol
Auteurs principaux: Ho-Mahler, Nancy, Turner, Beni, Eaddy, Michael, Hanke, Mark L, Nelson, Winnie W
Format: Artigo
Langue:Inglês
Publié: Dove 2020
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7039080/
https://ncbi.nlm.nih.gov/pubmed/32110122
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OARRR.S231667
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires